スポンサーリンク
国立がんセンター中央病院 画像診断グループ | 論文
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- A meta-analysis of ^F-Fluoride positron emission tomography for assessment of metastatic bone tumor
- Optimum emission time in deep-inspiration breath-hold PET-CT : a preliminary result
- FDG-PET for the diagnosis of fever of unknown origin : a Japanese multi-center study
- Assessment of tumor hypoxia by ^Cu-ATSM PET/CT as a predictor of response in head and neck cancer : a pilot study
- The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study